The bill shifts federal research away from animal testing toward validated non-animal methods—promising better human-relevant science, animal welfare improvements, and long-term savings—but risks near-term research disruption, gaps in necessary animal-based testing, added compliance costs, and political delays for urgent national-security or public-health work.
Researchers and patients: Federal support and requirements will accelerate development and adoption of human-relevant methods (human-cell models, organ-on-chip, AI), improving the reliability of translational research outcomes.
Scientists, federal contractors, and the research workforce: A Federal Research Modernization Fund plus training and transition support will speed validation of non-animal methods and help workers adapt skills.
Animals and animal welfare organizations: Federally funded facilities will be required to release research animals to accredited sanctuaries or shelters, increasing placements and reducing harms to animals.
Patients with chronic or emergent conditions and biomedical researchers: The bill’s effective ban on federally funded animal testing after three years could delay or halt drug development and other medical research, slowing medical advances.
Patients (including veterans) and researchers: Limited exemptions risk leaving gaps where animal studies are still the best validated option, potentially impeding development of treatments that currently rely on animal models.
Federal contractors, grantees, small research businesses, and nonprofits: New compliance costs, fines (up to $250,000), and possible debarment increase financial and operational risk for entities that currently use animals.
Based on analysis of 3 sections of legislative text.
Bars most federally funded animal research by agencies, contractors, and grantees, phases in prohibitions, creates alternatives programs and a preapproval process for narrow exceptions.
Prohibits federal departments, agencies, contractors, subcontractors, and grantees from using federal funds to conduct most research, testing, or experimentation that uses animals, with phased delays for certain fields and specific exceptions. The bill sets civil penalties and administrative sanctions for violations, requires a pre-approval process (including a one-year congressional joint-resolution authorization) for narrow national-security or infectious-disease uses, and creates programs and a fund to promote non-animal research methods and to release animals used in now-prohibited research.
Introduced March 3, 2025 by Nicole Malliotakis · Last progress March 3, 2025